FONTI DOCUMENTALI

BIBLIOGRAFIA

• European Society of Intensive Care Medicine (ESICM) guideline on transfusion strategies in nonbleeding critically ill adults. 2020. doi: 10.1007/s00134-019-05884-8
• National Institute for Health and Care Excellence (NICE) guideline on blood transfusion. NG24. 2015. https://www.nice.org.uk/guidance/ng24
• Red Blood Cell Transfusion 2023 AABB International Guidelines. 2023. https://jamanetwork.com/journals/jama/article-abstract/2810754#:~:text=Our%20panel%20recommends%20restrictive%20transfusion,that%20will%20differ%20between%20patients.
• Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. 2021. doi: 10.1007/s00134-021-06531-x
• Recommendations for the transfusion of plasma and platelets. 2009. doi: 10.2450/2009.0005-09
• Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia – 4th edition. 2021. https://thalassaemia.org.cy/publications/tif-publications/guidelines-for-the-management-of-transfusion-dependent-thalassaemia-4th-edition-2021-v2/
• British Committee for Standards in Haematology (BCSH) guidelines on use of platelet transfusions. 2017. doi: 10.1111/bjh.14423
• AABB Technical Manual 15th Edition, 2005
• Accordo Stato-Regioni del 16 dicembre 2010 contenente "Requisiti strutturali, tecnologici e organizzativi minimi per l'esercizio delle attività sanitarie dei servizi trasfusionali e delle unità di raccolta del sangue e degli emocomponenti e Modello per le visite di verifica dei servizi trasfusionali e delle unità di raccolta del sangue e degli emocomponenti"
• Accordo Stato-Regioni del 25 luglio 2012 contenente "Linee guida per l'accreditamento dei servizi trasfusionali e delle unità di raccolta del sangue e degli emocomponenti"
• American Association of Blood Banks. Standards for Blood Banks and Transfusion Services. 20th Edition. 2002.AABB, Bethesda.
• Andersen C. Critical haemoglobin thresholds in premature infants. Arch Dis Fetal Neonatal Ed 2001; 84: F146-8.
• Andrew M, Castle V, Saigal S, et al. Clinical impact of neonatal thrombocytopenia. J Pediatr 1987; 110: 457-64.
• Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-72
• Andrew M, Vegh P, Caco C, et al. Randomised controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993; 123; 285-91
• Andrew ME, Monagle P, deVeber G, Chan AKC. Thromboembolic disease and antithrombotic therapy in newborns [review]. (ASH) Hematology 2001;358-74.
• British Committee for Standards in Haematology. Blood Transfusion Task Force. Guidelines on the clinical use of leucocyte-depleted blood components. Transfusion Med 1998; 8: 59-71.
• British Committee for Standards in Haematology. Blood Transfusion. Task Force. Guidelines on gamma-irradiation of blood components for the prevention of transfusion associated graft-versus-host disease. Transfusion Med 1996; 6: 261-71.
• British Committee for Standards in Haematology. Blood Transfusion Task Force. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. Transfusion Med 1996; 6: 273-83.
• British Committee for Standards in Haematology. Guidelines for the Use of Platelet Transfusions. Br. J. Haematol 2003; 122: 10-23.
• British Committee for Standards in Haematology. The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol 2002; 119: 295.309.
• British Committee for Standards in Haematology. Transfusion guidelines for neonates and older children. Br J Haematol 2004;124: 433-53.
• Bundesärztekammer. Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. Köln: Deutscher Ärzte-Verlag; 2003. www.bundesärztekammer.de.
• Cairo MS. Immunotherapy in the prophylaxis and treatment of neonatal sepsis. Curr Opin Pediatr 2003; 15: 155.60.
• Carson JL, Hill S, Carless P, et al. Trasfusion triggers: a systematic review of the literature. Transfus Med Rev 2002; 16: 187-99.
• Carson JL, Stanworth SJ, Dennis JA, et al. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database of Systematic Reviews 2021, Issue 12. Art. No.: CD002042. DOI: 10.1002/14651858.CD002042.pub5. Accessed 01 October 2023.
• Carson JL, Triulzi DJ, Ness PM. Indications for and Adverse Effects of Red-Cell Transfusion. N Engl J Med 2017; 377:1261-1272. DOI: 10.1056/NEJMra1612789.
• Cochrane Injuries Group Albumin Reviewers. Human Albumin administration in critically ill patients: systematic review of randomised controlled trials. Br Med J 1998; 317: 235-40.
• Council of Europe Recommendation No R (95) 15 on the preparation, use and quality assurance of blood components. 11th edition. 2004. Council of Europe Publishing, Strasbourg.
• Dallman PR: In: Pediatrics, 16th ed. Rudolph A (editor). New York, Appleton-Century-Crofts, 1977, p.1111.
• Decreto 2 dicembre 2016: Programma nazionale plasma e medicinali plasmaderivati, anni 2016-2020
• Decreto Legislativo 20 dicembre 2007, n. 261 "Revisione del decreto legislativo 19 agosto 2005, n. 191, recante attuazione della direttiva 2002/98/CE che stabilisce norme di qualità e di sicurezza per la raccolta, il controllo, la lavorazione, la conservazione e la distribuzione del sangue umano e dei suoi componenti"
• Decreto Legislativo 6 novembre 2007, n. 191 "Attuazione della direttiva 2004/23/CE sulla definizione delle norme di qualità e di sicurezza per la donazione, l'approvvigionamento, il controllo, la lavorazione, la conservazione, lo stoccaggio e la distribuzione di tessuti e cellule umani"
• Decreto Legislativo 9 novembre 2007, n. 208 "Attuazione della direttiva 2005/62/CE che applica la direttiva 2002/98/CE per quanto riguarda le norme e le specifiche comunitarie relative ad un sistema di qualità per i servizi trasfusionali"
• Decreto Legislativo del 19 marzo 2018, n. 19 "Attuazione della direttiva (UE) 2016/1214 della Commissione del 25 luglio 2016, recante modifica della direttiva 2005/62/CE per quanto riguarda le norme e le specifiche del sistema di qualità per i servizi trasfusionali".
• Decreto Legislativo n. 191 del 19 Agosto 2005 Attuazione della direttiva 2002/98/CE che stabilisce norme di Qualità e sicurezza del sangue umano e dei suoi componenti (Applicazione 8-11-2005)
• Decreto Ministero Salute del 2 novembre 2015, "Disposizioni relative ai requisiti di qualità e sicurezza del sangue e degli emocomponenti"
• Del Vecchio A, Sola MC, Theriaque DW, et al. Platelet transfusions in the neonatal intensive care unit: factors predicting which patients will require multiple transfusions. Transfusion 2001; 41: 803-8.
• Direttiva 2002/98/CE del 27 gennaio 2003 "che stabilisce norme di qualità e di sicurezza per la raccolta, il controllo, la lavorazione, la conservazione e la distribuzione del sangue umano e dei suoi componenti e che modifica la direttiva 2001/83/CE"
• Direttiva 2004/33/CE del 22 marzo 2004 "che applica la direttiva 2002/98/CE del Parlamento europeo e del Consiglio relativa a taluni requisiti tecnici del sangue e degli emocomponenti"
• Direttiva 2005/61/CE del 30 settembre 2005 "che applica la direttiva 2002/98/CE del Parlamento europeo e del Consiglio per quanto riguarda le prescrizioni in tema di rintracciabilità e la notifica di effetti indesiderati ed incidenti gravi"
• Direttiva 2005/62/CE del 30 settembre 2005 "recante applicazione della direttiva 2002/98/CE del Parlamento europeo e del Consiglio per quanto riguarda le norme e le specifiche comunitarie relative ad un sistema di qualità per i servizi trasfusionali"
• Direttiva 2016/1214/CE del 25 luglio 2016 "recante modifica della direttiva 2005/62/CE per quanto riguarda le norme e le specifiche del sistema di qualità per i servizi trasfusionali"
• Duguid JK, Minards J, Bolton-Maggs PH. Lesson of the week: incompatible plasma transfusions and haemolysis in children. Br Med J 1999; 318: 176-7.
• Eder AF, Manno CS. Does red cell T activation matter? Br J Haematol 2001; 114: 25-30.
• Eugster M, Reinhart WH. The influence of the haematocrit on primary haemostasis in vitro. Thromb Haemost 2005; 94: 1213-8
• Floss AM, Strauss RG, Goeken N, Knox L. Multiple transfusions fail to provoke antibodies against blood cell antigens in human infants. Transfusion 1986; 26: 419-22.
• Foukaneli T, Kerr P, Bolton-Maggs PHB, et al. Guidelines on the use of irradiated blood components. Br. J. Haematol 2020; 191:704-724. https://doi.org/10.1111/bjh.17015. Disponibile al seguente link: https://onlinelibrary.wiley.com/share/7T6QW5F3CZ9DVCUFSV7E?target=10.1111/bjh.17015.
• Prokopchuk-Gauk O, Robitaille N, Tinmouth A, Shih A, Musuka C, Devine D, et al. Recommendations for use of Irradiated Blood Components in Canada: A NAC and CCNMT Collaborative Initiative. Ottawa: National Advisory Committee on Blood and Blood Products; October 17, 2017 [updated 2023 10 16]. Disponibile al seguente link: https://nacblood.ca/en/resource/recommendations-use-irradiated-blood-components-canada.
• Wiersum-Osselton JC, Slomp J, Falkenburg JHF, Geltink T, van Duijnhoven HLP, Netelenbos T, Schipperus MR. Guideline development for prevention of transfusion-associated graft-versus-host disease: reduction of indications for irradiated blood components after prestorage leukodepletion of blood components. British Journal of Haematology. 195: 681-8, 2021. Disponibile al seguente link: https://onlinelibrary.wiley.com/share/UYQMC9GWFJGKIXDUDN9H?target=10.1111/bjh.17822.
• Guide to the preparation, use and quality assurance of BLOOD COMPONENTS; EDQM 19th Edition, 2017.
• Hambleton J, Leung LL, Levi L. Coagulation: consultative hemostasis. (ASH) Hematology 2002; 335-52
• Heal MH, Blumberg N. Optimizig platelet transfusion therapy. Blood Reviews 2004; 18: 149-65 Stanworth SJ, Hyde C, Brunskill S, Murphy MF: Platelet transfusion prophylaxis for patient with haematological malignancies: where to now? Br J Haematol 2005; 131: 588-95
• Huber J, Stanworth SJ, Doree C, et al. Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures. Cochrane Database Syst Rev. 2019 Nov 28;11(11):CD012745. doi: 10.1002/14651858.CD012745.pub2.
• International Forum. Prevention of post-transfusion cytomegalovirus: leucoreduction or screening? Vox Sang 2002; 83: 72-8.
• ISTAT – Istituto Nazionale di Statistica. Indicatori demografici. Anno 2022. https://www.istat.it/it/files/2023/04/indicatori-anno-2022.pdf
• Istituto Superiore di Sanità. Atti del Convegno Nazionale Buon Uso del Sangue, Roma, 25-26 febbraio 2003. Rapporti ISTISAN 04/10.
• Josephson CD, Su LL, Hillyer KL, Hillyer CD. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guideline. Transfus Med Rev 2007; 21:118-33
• Karam O, Tucci M, Combescure C, et al. Plasma transfusion strategies for critically ill patients. Cochrane Database Syst Rev. 2013 Dec 28;(12):CD010654. doi: 10.1002/14651858.CD010654.pub2.
• Laupacis A, Brown J, Costello B et al. Prevention of posttransfusion CMV in the era of universal leukoreduction: a consensus statement. Transfusion 2001; 41: 560-96.
• Lee RH, Kasthuri RS, Bergmeier W. Platelet transfusion for patients with platelet dysfunction: effectiveness, mechanisms, and unanswered questions. Curr Opin Hematol. 2020 Nov;27(6):378-385. doi: 10.1097/MOH.0000000000000608.
• Legge 21 ottobre 2005, n. 219, recante "Nuova disciplina per le attività trasfusionali e della produzione nazionale degli emoderivati"
• Lenet T, Baker L, Park L, et al. A Systematic Review and Meta-analysis of Randomized Controlled Trials Comparing Intraoperative Red Blood Cell Transfusion Strategies. Ann Surg. 2022 Mar 1;275(3):456-466. doi: 10.1097/SLA.0000000000004931.
• Levi M, Ten Cate H. Disseminated intravascular coagulation [review]. N Engl J Med 1999; 341: 586-92.
• Lippi G, Favaloro EJ, Buoro S. Platelet Transfusion Thresholds: How Low Can We Go in Respect to Platelet Counting? Semin Thromb Hemost. 2020 Apr;46(3):238-244. doi: 10.1055/s-0039-1696943. Epub 2019 Sep 28.
• Ludvigsen CW Jr, Swanson JL, Thompson TR, McCullough J. The failure of neonates to form red blood cell alloantibodies in response to multiple transfusions.Am J Clin Pathol 1987; 87: 250-1.
• Maier RF, Obladen M, Kattner E, et al. High- versus lowdose erythropoietin in extremely low birth weight infants. J Pediatr 1998; 132: 866-70.
• Miyashiro AM, dos Santos N, Guinsburg R, et al. Strict red blood cell transfusion guideline reduces the need for transfusions in very-low-birthweight infants in the first 4 weeks of life: a multicentre trial.Vox Sang 2005; 88: 107-13.
• Mohan P, Brocklehurst P. 51) Hambleton J, Leung LL, Levi L. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia [review]. Cochrane Database Syst Rev 2003; (4): CD003956.
• Murray N A, Roberts IAG. Neonatal transfusion practice. Arch Dis Child Fetal Neonatal Ed 2004; 89: F101.7. Gruppo di Studio SIMTI-SIN Blood Transfus 2006; 4: 158-80
• Mussi-Pinhata MM, Pinto PC, YamamotoAY, et al. Placental transfer of naturally acquired, maternal citomegalovirus antibodies in term and preterm neonates. J Med Virol 2003; 69: 232-9.
• Nahirniak S, Slichter SJ, Tanael S, et al. Guidance on platelet transfusion for patients with hypoproliferative thrombocytopenia. Transfus Med Rev. 2015 Jan;29(1):3-13. doi: 10.1016/j.tmrv.2014.11.004.
• Northern Neonatal Nursing Initiative Trial Group. Randomised trial of prophylactic early fresh frozen plasma, gelatin or glucose in pre-term babies: outcome at 2 years. Lancet 1996; 348: 229-32.
• Nuova Disciplina delle attività trasfusionali e della produzione nazionale degli emoderivati (applicazione 11 Novembre 2005)
• Osterman JL, Arora S. Blood Product Transfusions and Reactions. Hematol Oncol Clin North Am. 2017 Dec;31(6):1159-1170. doi: 10.1016/j.hoc.2017.08.014.
• PDTA "Gestione dell'anemia ferrocarenziale in Pronto Soccorso" Ed. 00 Rev.00 16.10.2023. Grande Ospedale Metropolitano "Bianchi Melacrino Morelli" Reggio Calabria.
• PDTA "Anemie" Rev.00 11.10.2018. Grande Ospedale Metropolitano "Bianchi Melacrino Morelli" Reggio Calabria.
• Practice guidelines for perioperative blood transfusion and adjuvant therapies: an update report by the American Society of Anestesiologists Task Force on perioperative blood transfusion and adjuvant therapies. Anesthesiology 2006; 105: 198-208
• Preiksaitis JK, Brown L, McKenzie M. Transfusion-acquired cytomegalovirus infection in neonates. A prospective study. Transfusion 1988; 28: 205-9.
• Preiksaitis JK. The cytomegalovirus-.safe. blood product: is leukoreduction equivalent to antibody screening? Transfus Med Rev 2000; 14: 112-36.
• Pupella S, Girelli G, Casadei AM, et al. Protocollo operativo per la terapia trasfusionale del neonato: risultati preliminari. La Trasf del Sangue 1999; 44: 298-303.
• Putaggio A, Tigano S, Caruso A, et al. Red Blood Cell Transfusion Guided by Hemoglobin Only or Integrating Perfusion Markers in Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis with Trial Sequential Analysis. J Cardiothorac Vasc Anesth. 2023 Nov;37(11):2252-2260. doi: 10.1053/j.jvca.2023.08.001.
• Raccomandazioni per la terapia trasfusionale neonatale. SIMTI-SIN
• Ramasethu J, Luban NLC. T activation. Br J Haematol 2001; 112: 259-63
• Ratko TA, Cummings JP, Oberman HA, et al. Evidence-based recommendations for the use of WBC reduced cellular blood components. Transfusion,2001; 41: 1310
• Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G, Barbui T, Mandelli F, Sirchia G. for the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med 1997; 337: 1870.
• Rebulla P. Platelet transfusion trigger in difficult patients. Transf Clin Biol 2001; 8: 249-54 Wandt H, Schaefer-eckart K, Frank M, et al. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2006; 37: 387-92
• Roberts I, Murray NA. Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed 2003;88: F359.64
• Rodeck CH, Deans A. Red cell allo-immunisation. In: Fetal Medicine: Basic Science and Clinical Practice. Rodeck CH, Whittle MJ (editors). Churchill Livingstone, NewYork, 1999. p. 785-804.
• Romagnoli C. "Percorsi Assistenziali Neonatologici" Biomedia Edizione 2016
• Ronghe MD, Foot AB, Cornish JM, et al. The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation. Br J Haematol 2002;118: 124-7.
• Roseff SD, Luban NLC, Manno CS. Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 2002; 42: 1398-413.
• Ross MP, Christensen RD, Rothstein G et al. A randomized trial to develop criteria for administering erythrocyte transfusions to anemic preterm infants 1 to 3 months of age. J Perinatol 1989; 9: 246-53.
• Santagostino E, Mancuso ME, Morfini M, et al. Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy. Haematologica 2006; 91: 634-9.
• Schiffer AC, Anderson KC, Bennet CL, et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.J Clin Oncol 2001; 19: 1519-38 Lawrence JB, Yomtovian RA, Hammons T, et al. Lowering the prophylactic platelet transfusion threshold: a prospective analysis. Leuk Lymphoma 2001; 41:67-76
• Schiffer CA, Bohlke K, Delaney M, et al. Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018 Jan 20;36(3):283-299. doi: 10.1200/JCO.2017.76.1734.
• Shannon KM, Mentzer WC, Abels RI, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995; 95: 1-8.
• Simonetti RG, Perricone G, Nikolova D, et al. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis. Cochrane Database Syst Rev. 2019 Jun 28;6(6):CD004039. doi: 10.1002/14651858.CD004039.pub2.
• Slichter Sj, Davis K, Enright H, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005; 105: 4106-14 Società Italiana di Medicina Trasfusionale e Immunoematologia (SIMTI). Standard di Medicina Trasfusionale.1st Edition, September 2007. Edizioni SIMTI, Italy.
• So KW, Fok TF, Ng PC, WongWW, Cheung KL. Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants. Arch Dis Child Fetal Neonatal Ed 1997; 76: F43-6.
• Solves Alcaina P. Platelet Transfusion: And Update on Challenges and Outcomes. J Blood Med. 2020 Jan 24;11:19-26. doi: 10.2147/JBM.S234374.
• Stainsby D, McLennan S, Hamilton PJ. Management of massive blood loss: a template guideline. British Journal of Anaestesia 2000, 85:487-491
• Standard di Medicina Trasfusionale, SIMTI, 3° edizione Maggio 2017
• Stanworth SI, Brunskill SJ, Hyde CJ, et al. Is fresh frozen plasma clinically effective? Asystematic review of randomized controlled trials. Br J Haematol 2004; 126: 139-52.
• Strauss RG, Johnson K, Cress G, Cordle DG. Alloimmunization in preterm infants after repeated transfusions of WBC-reduced RBCs from the same donor. Transfusion 2000; 40: 1463-8.
• Strauss RG. Controversies in the management of the anemia of prematurity using single-donor red blood cell transfusions and/or recombinant human erythropoietin. Transfus Med Rev 2006; 20: 34-44.
• Strauss RG. Transfusion approach to neonatal anemia. Neo Reviews 2000; l:74-80.
• Tibi P, McClure RS, Huang J, et al. STS/SCA/AmSECT/SABM Update to the Clinical Practice Guidelines on Patient Blood Management. J Cardiothorac Vasc Anesth. 2021 Sep;35(9):2569-2591. doi: 10.1053/j.jvca.2021.03.011.
• Tinmouth AT.,Freedman J.Prophylactic Platelet Transfusions: Which Dose Is the Best Dose? A Review of the Literature. Transf Med Reviews 2003;17:181-193
• Van der Linden P. Transfusion strategy. Eur J Anaesth 2001;18:495-8
• Vaupel P, Mayer A. Hypoxia and anemia: effects on tumor biology and treatment resistance.Transfusion Clin Biol 2005; 12: 5-10
• Wardle SP, Crawley E, Yoxall CW et al. Peripheral oxygenation and anaemia in preterm babies. Pediatr Res 1998; 44:125. 31.
• Yarranton H, Cohen H, Pavord SR, et al: Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura. Br. J Haematol 2003, 121:778-785.